BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to legal issues life sciences companies face when dealing with the FDA. Topics discussed include:

• Utah’s emergence as a national and global player in the life sciences industry
• Life sciences regulatory legal issues
• Updates at the FDA
• Negotiating with the FDA during the review process
• Much more